Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Classifica tra le azioni #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Prezzo delle azioni
$0.21291741
Ultima sincronizzazione: 2025-04-18
Capitalizzazione di mercato
$12.07M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
KR
Scambia PCL, Inc. (241820)

Categoria

Ricavi di PCL, Inc. (241820)
Ricavi nel Sep 2025 TTM: $3.55M
Secondo gli ultimi rapporti finanziari di PCL, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $3.55M. Nel 2023, l'azienda ha registrato ricavi di $6.51M una diminuzione rispetto a i ricavi dell'anno 2022, che erano pari a $29.49M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per PCL, Inc. da 2015 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $3.55M 318.67%
2024 $847.63K -86.98%
2023 $6.51M -77.92%
2022 $29.49M -24.02%
2021 $38.82M -21.50%
2020 $49.45M 159,346.74%
2019 $31.01K -73.14%
2018 $115.44K -75.69%
2017 $474.92K -2.74%
2016 $488.29K 136.13%
2015 $206.79K 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$46.59B 1,312,601.74%
US
$25.84B 727,951.41%
US
$35.48B 999,790.71%
IE
$21.00B 591,538.63%
US
$6.51B 183,407.73%
US